ANI Pharmaceuticals To Present At September Investor Conferences

(MENAFN- GlobeNewsWire - Nasdaq) PRINCETON, N.J., Sept. 03, 2026 (GLOBE NEWSWIRE) -- ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced that Nikhil Lalwani, President and Chief Executive Officer, along with members of the Company's executive leadership team, will participate in fireside chats at the following upcoming investor conferences:

Event	2026 Wells Fargo Healthcare Conference
Date	Thursday, September 10, 2026
Time	1:30 p.m. ET
Webcast	Click here
Event	Morgan Stanley 24th Annual Global Healthcare Conference
Date	Monday, September 14, 2026
Time	7:00 a.m. ET
Webcast	Click here
Event	H.C. Wainwright 28th Annual Global Investment Conference
Date	Tuesday, September 15, 2026
Time	12.00 p.m. ET
Webcast	Click here

The live and archived webcasts will also be accessible from the Company's website at , in the Investors section under Events and Presentations.

About ANI

ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified biopharmaceutical company committed to its mission of“Serving Patients, Improving Lives" by developing, manufacturing, and commercializing innovative and high-quality therapeutics. The Company is focused on delivering sustainable growth through its Rare Disease business, which markets novel products in the areas of ophthalmology, rheumatology, nephrology, neurology, and pulmonology; its Generics business, which leverages R&D expertise, operational excellence, and U.S.-based manufacturing; and its Brands business. For more information, visit

Investor Relations:
Irina Koffler, Vice President, Investor Relations
T: 917-734-7387
E:...

Media Relations:
Argot Partners
T: 212-600-1494
E:...

SOURCE: ANI Pharmaceuticals, Inc.

MENAFN03092026004107003653ID1111616812